Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zfp263
|
ENSMUSG00000022529.5 | zinc finger protein 263 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr16_3743828_3744151 | Zfp263 | 104 | 0.945077 | 0.43 | 1.1e-03 | Click! |
chr16_3743267_3743762 | Zfp263 | 579 | 0.632189 | 0.13 | 3.3e-01 | Click! |
chr16_3744222_3744483 | Zfp263 | 8 | 0.962027 | 0.12 | 3.9e-01 | Click! |
chr16_3744539_3744690 | Zfp263 | 17 | 0.961651 | 0.11 | 4.2e-01 | Click! |
chr16_3740315_3740495 | Zfp263 | 3688 | 0.144408 | 0.11 | 4.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_141750503_141750994 | 32.17 |
Agmat |
agmatine ureohydrolase (agmatinase) |
4076 |
0.15 |
chr1_192115353_192115664 | 24.29 |
Rcor3 |
REST corepressor 3 |
838 |
0.5 |
chr1_86525613_86527056 | 17.90 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr3_101552255_101552604 | 17.87 |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
25131 |
0.16 |
chr3_84135410_84135679 | 14.08 |
Mnd1 |
meiotic nuclear divisions 1 |
20242 |
0.18 |
chr8_120486990_120488549 | 12.51 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr9_63757305_63758776 | 11.69 |
Smad3 |
SMAD family member 3 |
46 |
0.98 |
chr8_122329580_122330425 | 10.39 |
Zfpm1 |
zinc finger protein, multitype 1 |
3696 |
0.15 |
chr14_14351950_14353283 | 10.38 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr4_118489750_118490166 | 9.17 |
Tie1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
103 |
0.94 |
chr18_35848127_35849279 | 8.59 |
Cxxc5 |
CXXC finger 5 |
5984 |
0.11 |
chr17_28176553_28177770 | 8.42 |
Zfp523 |
zinc finger protein 523 |
2 |
0.89 |
chr1_132027396_132027547 | 8.38 |
Mfsd4a |
major facilitator superfamily domain containing 4A |
1562 |
0.3 |
chr17_5093326_5093711 | 8.27 |
Gm15599 |
predicted gene 15599 |
18592 |
0.23 |
chr11_88068171_88069196 | 8.01 |
Vezf1 |
vascular endothelial zinc finger 1 |
404 |
0.76 |
chr7_19672641_19672962 | 7.86 |
Apoc2 |
apolipoprotein C-II |
1119 |
0.26 |
chr4_140701770_140702866 | 7.78 |
Rcc2 |
regulator of chromosome condensation 2 |
845 |
0.47 |
chr13_45389281_45390472 | 7.76 |
Mylip |
myosin regulatory light chain interacting protein |
134 |
0.97 |
chr11_77983926_77984968 | 7.69 |
Phf12 |
PHD finger protein 12 |
1645 |
0.25 |
chr7_142574309_142575453 | 7.51 |
H19 |
H19, imprinted maternally expressed transcript |
1657 |
0.21 |
chr1_74000776_74000971 | 7.38 |
Tns1 |
tensin 1 |
694 |
0.75 |
chr1_181256749_181257169 | 7.29 |
Rpl35a-ps2 |
ribosomal protein L35A, pseudogene 2 |
14639 |
0.14 |
chr4_108318809_108318986 | 7.05 |
Gm12740 |
predicted gene 12740 |
3441 |
0.16 |
chr3_144201827_144203140 | 6.96 |
Lmo4 |
LIM domain only 4 |
87 |
0.97 |
chr11_115911824_115912039 | 6.91 |
Smim6 |
small integral membrane protein 6 |
86 |
0.93 |
chr17_45994580_45994782 | 6.81 |
Vegfa |
vascular endothelial growth factor A |
26691 |
0.14 |
chr7_24370802_24371069 | 6.72 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
597 |
0.53 |
chr11_75563973_75564288 | 6.65 |
Slc43a2 |
solute carrier family 43, member 2 |
1877 |
0.19 |
chr1_82816421_82816691 | 6.62 |
Gm28942 |
predicted gene 28942 |
3279 |
0.12 |
chr3_30507827_30509444 | 6.62 |
Mecom |
MDS1 and EVI1 complex locus |
852 |
0.52 |
chr6_136857148_136857514 | 6.50 |
Art4 |
ADP-ribosyltransferase 4 |
402 |
0.71 |
chr2_131136141_131136403 | 6.49 |
Gm11037 |
predicted gene 11037 |
2775 |
0.14 |
chr12_103956494_103956864 | 6.41 |
Serpina1e |
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
219 |
0.88 |
chr6_55323093_55323414 | 6.38 |
Aqp1 |
aquaporin 1 |
13179 |
0.14 |
chr6_125166797_125167506 | 6.34 |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
684 |
0.39 |
chr11_4576151_4576309 | 6.28 |
Gm11960 |
predicted gene 11960 |
12598 |
0.15 |
chr7_110774760_110775022 | 6.20 |
Ampd3 |
adenosine monophosphate deaminase 3 |
647 |
0.63 |
chr7_115894816_115894968 | 6.11 |
Sox6 |
SRY (sex determining region Y)-box 6 |
35040 |
0.2 |
chr2_170130477_170131578 | 6.02 |
Zfp217 |
zinc finger protein 217 |
193 |
0.97 |
chr19_38120210_38120386 | 6.00 |
Rbp4 |
retinol binding protein 4, plasma |
4427 |
0.16 |
chr15_99259950_99260152 | 5.95 |
Gm25999 |
predicted gene, 25999 |
5037 |
0.1 |
chr14_20768613_20768995 | 5.92 |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
3295 |
0.15 |
chr11_102347634_102348245 | 5.91 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
12629 |
0.1 |
chr17_5941337_5942051 | 5.88 |
Synj2 |
synaptojanin 2 |
291 |
0.89 |
chr11_31843822_31844223 | 5.82 |
Gm12107 |
predicted gene 12107 |
11362 |
0.18 |
chr1_165765728_165766269 | 5.81 |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
2252 |
0.15 |
chr7_19817396_19818051 | 5.79 |
Gm16174 |
predicted gene 16174 |
1170 |
0.22 |
chr6_136856102_136856384 | 5.79 |
Art4 |
ADP-ribosyltransferase 4 |
1490 |
0.22 |
chr12_32123672_32123838 | 5.79 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
53 |
0.98 |
chr1_132417296_132418099 | 5.73 |
Dstyk |
dual serine/threonine and tyrosine protein kinase |
93 |
0.96 |
chr11_102316544_102317735 | 5.73 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
148 |
0.92 |
chr13_59835574_59835725 | 5.66 |
Gm34961 |
predicted gene, 34961 |
12383 |
0.11 |
chr11_77607040_77608322 | 5.64 |
Taok1 |
TAO kinase 1 |
134 |
0.94 |
chr8_122546140_122546405 | 5.63 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
5057 |
0.1 |
chr3_51340298_51341882 | 5.62 |
Elf2 |
E74-like factor 2 |
427 |
0.74 |
chr17_25944896_25945091 | 5.57 |
Nhlrc4 |
NHL repeat containing 4 |
32 |
0.5 |
chr8_124019948_124020121 | 5.55 |
Taf5l |
TATA-box binding protein associated factor 5 like |
906 |
0.35 |
chr13_36056619_36056809 | 5.53 |
Fars2 |
phenylalanine-tRNA synthetase 2 (mitochondrial) |
60698 |
0.08 |
chr7_25686729_25687529 | 5.49 |
Tgfb1 |
transforming growth factor, beta 1 |
127 |
0.91 |
chr12_84854920_84855096 | 5.46 |
D030025P21Rik |
RIKEN cDNA D030025P21 gene |
20761 |
0.12 |
chr2_119744264_119744580 | 5.41 |
Itpka |
inositol 1,4,5-trisphosphate 3-kinase A |
2085 |
0.18 |
chr1_130731762_130732102 | 5.41 |
AA986860 |
expressed sequence AA986860 |
44 |
0.94 |
chr5_124598611_124598788 | 5.40 |
Tctn2 |
tectonic family member 2 |
50 |
0.96 |
chr4_154911160_154911660 | 5.38 |
Prxl2b |
peroxiredoxin like 2B |
12275 |
0.11 |
chr4_152092573_152092747 | 5.37 |
Plekhg5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
4059 |
0.14 |
chr17_75551163_75552443 | 5.36 |
Fam98a |
family with sequence similarity 98, member A |
7 |
0.99 |
chr11_115898961_115899323 | 5.30 |
Smim5 |
small integral membrane protein 5 |
824 |
0.4 |
chr4_45402888_45403200 | 5.30 |
Slc25a51 |
solute carrier family 25, member 51 |
1822 |
0.27 |
chr7_19796786_19796974 | 5.29 |
Cblc |
Casitas B-lineage lymphoma c |
71 |
0.92 |
chr15_100699420_100699696 | 5.26 |
Galnt6os |
polypeptide N-acetylgalactosaminyltransferase 6, opposite strand |
3778 |
0.13 |
chr5_143561547_143562201 | 5.24 |
Fam220a |
family with sequence similarity 220, member A |
12834 |
0.14 |
chr4_117830537_117830707 | 5.22 |
Slc6a9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
3884 |
0.14 |
chr10_126978694_126979699 | 5.19 |
Ctdsp2 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
167 |
0.89 |
chr3_153690441_153690884 | 5.15 |
Gm22206 |
predicted gene, 22206 |
18249 |
0.16 |
chr3_103799140_103799457 | 5.14 |
Gm15471 |
predicted gene 15471 |
3831 |
0.09 |
chr3_127930721_127931028 | 5.09 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
14702 |
0.14 |
chr3_86224766_86224976 | 5.08 |
Lrba |
LPS-responsive beige-like anchor |
191 |
0.93 |
chr18_56871580_56871757 | 5.08 |
Gm18087 |
predicted gene, 18087 |
44420 |
0.14 |
chr15_6520395_6520755 | 5.06 |
Fyb |
FYN binding protein |
2278 |
0.34 |
chr5_111263136_111263333 | 5.05 |
Ttc28 |
tetratricopeptide repeat domain 28 |
27919 |
0.16 |
chr11_120630519_120630818 | 5.05 |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
32 |
0.91 |
chr2_170151630_170151806 | 5.04 |
Zfp217 |
zinc finger protein 217 |
3615 |
0.34 |
chr11_115899580_115900578 | 5.01 |
Smim5 |
small integral membrane protein 5 |
99 |
0.93 |
chr4_46407004_46407329 | 4.98 |
Hemgn |
hemogen |
2930 |
0.18 |
chr7_16815354_16816404 | 4.98 |
Strn4 |
striatin, calmodulin binding protein 4 |
10 |
0.69 |
chr14_74672532_74672729 | 4.94 |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A |
31790 |
0.17 |
chr11_87986817_87988025 | 4.93 |
Dynll2 |
dynein light chain LC8-type 2 |
65 |
0.96 |
chr11_52350840_52351201 | 4.92 |
Vdac1 |
voltage-dependent anion channel 1 |
9840 |
0.17 |
chr7_19673044_19673413 | 4.90 |
Apoc2 |
apolipoprotein C-II |
692 |
0.43 |
chr10_80576603_80578409 | 4.89 |
Klf16 |
Kruppel-like factor 16 |
185 |
0.86 |
chr5_104062794_104062959 | 4.88 |
Gm43333 |
predicted gene 43333 |
9449 |
0.1 |
chr4_118240396_118240604 | 4.83 |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
4055 |
0.2 |
chr12_71932516_71932675 | 4.81 |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
42865 |
0.15 |
chr4_154025644_154026533 | 4.80 |
Smim1 |
small integral membrane protein 1 |
51 |
0.95 |
chr18_61278743_61279039 | 4.78 |
Pde6a |
phosphodiesterase 6A, cGMP-specific, rod, alpha |
3868 |
0.21 |
chr7_66280648_66280799 | 4.77 |
Lrrk1 |
leucine-rich repeat kinase 1 |
1494 |
0.38 |
chr15_84311105_84311461 | 4.75 |
Gm22890 |
predicted gene, 22890 |
12069 |
0.15 |
chr6_88251891_88252063 | 4.74 |
1700031F10Rik |
RIKEN cDNA 1700031F10 gene |
26299 |
0.12 |
chr6_128525636_128525787 | 4.72 |
Pzp |
PZP, alpha-2-macroglobulin like |
992 |
0.34 |
chr4_137751768_137751925 | 4.68 |
Alpl |
alkaline phosphatase, liver/bone/kidney |
4699 |
0.21 |
chr12_83375440_83375754 | 4.68 |
Dpf3 |
D4, zinc and double PHD fingers, family 3 |
24702 |
0.22 |
chr4_133599588_133600008 | 4.67 |
Sfn |
stratifin |
2370 |
0.16 |
chr16_8603622_8604209 | 4.66 |
Abat |
4-aminobutyrate aminotransferase |
8963 |
0.12 |
chr3_88553516_88553992 | 4.65 |
Ubqln4 |
ubiquilin 4 |
4 |
0.9 |
chr9_32696120_32696626 | 4.64 |
Ets1 |
E26 avian leukemia oncogene 1, 5' domain |
11 |
0.98 |
chr11_12036502_12038049 | 4.63 |
Grb10 |
growth factor receptor bound protein 10 |
126 |
0.97 |
chr1_85668278_85668429 | 4.63 |
Sp100 |
nuclear antigen Sp100 |
3472 |
0.14 |
chr11_100860094_100860970 | 4.59 |
Stat5a |
signal transducer and activator of transcription 5A |
47 |
0.96 |
chr11_119939229_119939473 | 4.59 |
Gm11766 |
predicted gene 11766 |
840 |
0.46 |
chr15_95883474_95883993 | 4.58 |
Gm25070 |
predicted gene, 25070 |
3916 |
0.23 |
chr1_170609925_170610258 | 4.56 |
Nos1ap |
nitric oxide synthase 1 (neuronal) adaptor protein |
20230 |
0.16 |
chr11_110448430_110448605 | 4.55 |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
28860 |
0.23 |
chr10_41196287_41196631 | 4.54 |
Gm25526 |
predicted gene, 25526 |
19586 |
0.18 |
chr10_89791896_89792070 | 4.54 |
Uhrf1bp1l |
UHRF1 (ICBP90) binding protein 1-like |
4783 |
0.23 |
chr5_137510563_137511218 | 4.53 |
Gm8066 |
predicted gene 8066 |
637 |
0.45 |
chr3_95675100_95675744 | 4.53 |
Adamtsl4 |
ADAMTS-like 4 |
1729 |
0.22 |
chrX_51204673_51205680 | 4.53 |
Mbnl3 |
muscleblind like splicing factor 3 |
656 |
0.65 |
chr6_72272236_72272936 | 4.53 |
Sftpb |
surfactant associated protein B |
32024 |
0.11 |
chr2_166702991_166703160 | 4.49 |
Prex1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
519 |
0.8 |
chr7_103813259_103814109 | 4.48 |
Hbb-bt |
hemoglobin, beta adult t chain |
312 |
0.71 |
chr4_135312473_135312670 | 4.47 |
Gm12982 |
predicted gene 12982 |
4601 |
0.13 |
chr9_48340771_48341057 | 4.46 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
16 |
0.98 |
chr19_9989423_9989765 | 4.46 |
Best1 |
bestrophin 1 |
3321 |
0.13 |
chr13_111686492_111687222 | 4.45 |
Mier3 |
MIER family member 3 |
45 |
0.97 |
chr7_19768312_19768686 | 4.42 |
Bcam |
basal cell adhesion molecule |
1996 |
0.13 |
chr2_153241340_153242013 | 4.41 |
Pofut1 |
protein O-fucosyltransferase 1 |
98 |
0.7 |
chr11_32256230_32256421 | 4.39 |
Nprl3 |
nitrogen permease regulator-like 3 |
88 |
0.94 |
chr5_112001700_112002600 | 4.38 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr1_165769100_165769265 | 4.37 |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
294 |
0.8 |
chr11_95808504_95808830 | 4.36 |
Phospho1 |
phosphatase, orphan 1 |
15832 |
0.1 |
chr11_114066488_114067724 | 4.35 |
Sdk2 |
sidekick cell adhesion molecule 2 |
60 |
0.98 |
chr11_5782627_5782808 | 4.32 |
Dbnl |
drebrin-like |
5771 |
0.12 |
chr7_38217395_38217753 | 4.31 |
Plekhf1 |
pleckstrin homology domain containing, family F (with FYVE domain) member 1 |
10442 |
0.13 |
chr3_116389186_116389497 | 4.31 |
Cdc14a |
CDC14 cell division cycle 14A |
16147 |
0.15 |
chr9_62838488_62838893 | 4.30 |
Cln6 |
ceroid-lipofuscinosis, neuronal 6 |
95 |
0.95 |
chr4_154021521_154021945 | 4.30 |
Lrrc47 |
leucine rich repeat containing 47 |
2094 |
0.17 |
chr11_102218354_102219649 | 4.28 |
Hdac5 |
histone deacetylase 5 |
72 |
0.94 |
chr12_110737482_110738077 | 4.27 |
Wdr20 |
WD repeat domain 20 |
165 |
0.94 |
chr1_93432204_93432382 | 4.27 |
Hdlbp |
high density lipoprotein (HDL) binding protein |
8499 |
0.12 |
chr19_55253850_55254459 | 4.27 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
785 |
0.62 |
chr3_51361175_51361331 | 4.26 |
Gm37203 |
predicted gene, 37203 |
8969 |
0.1 |
chr4_141746970_141747121 | 4.24 |
Agmat |
agmatine ureohydrolase (agmatinase) |
373 |
0.8 |
chr11_4031679_4031852 | 4.23 |
Sec14l4 |
SEC14-like lipid binding 4 |
18 |
0.96 |
chr7_19558533_19558808 | 4.23 |
Ppp1r37 |
protein phosphatase 1, regulatory subunit 37 |
4406 |
0.1 |
chr9_105494412_105494998 | 4.22 |
Atp2c1 |
ATPase, Ca++-sequestering |
41 |
0.97 |
chr6_38917703_38917854 | 4.21 |
Tbxas1 |
thromboxane A synthase 1, platelet |
1202 |
0.51 |
chr5_115436438_115437458 | 4.21 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
304 |
0.74 |
chr3_94372691_94372850 | 4.20 |
Rorc |
RAR-related orphan receptor gamma |
24 |
0.93 |
chr12_12941527_12942979 | 4.19 |
Mycn |
v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived |
339 |
0.83 |
chr1_154034449_154034624 | 4.19 |
Gm28286 |
predicted gene 28286 |
235 |
0.92 |
chr10_80160842_80161483 | 4.18 |
Cirbp |
cold inducible RNA binding protein |
4823 |
0.09 |
chr9_107975396_107975585 | 4.17 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
15 |
0.92 |
chr11_96318827_96319554 | 4.17 |
Hoxb4 |
homeobox B4 |
923 |
0.28 |
chr11_77491142_77492052 | 4.16 |
Ankrd13b |
ankyrin repeat domain 13b |
1919 |
0.19 |
chr14_53729986_53730169 | 4.15 |
Trav13-3 |
T cell receptor alpha variable 13-3 |
519 |
0.72 |
chrX_168673064_168674616 | 4.15 |
Msl3 |
MSL complex subunit 3 |
58 |
0.98 |
chr3_153858991_153859142 | 4.14 |
Gm24395 |
predicted gene, 24395 |
5741 |
0.1 |
chr5_28055448_28055803 | 4.13 |
Gm26608 |
predicted gene, 26608 |
166 |
0.94 |
chr11_64843201_64843493 | 4.11 |
Gm12292 |
predicted gene 12292 |
406 |
0.9 |
chr14_120705317_120705468 | 4.09 |
Rpl19-ps5 |
ribosomal protein L19, pseudogene 5 |
7686 |
0.21 |
chr5_23850355_23851323 | 4.07 |
2700038G22Rik |
RIKEN cDNA 2700038G22 gene |
238 |
0.81 |
chr4_133813137_133813697 | 4.06 |
Gm12974 |
predicted gene 12974 |
3003 |
0.18 |
chr14_53337554_53337726 | 4.05 |
Gm43650 |
predicted gene 43650 |
6282 |
0.19 |
chr18_61952693_61953227 | 4.05 |
Sh3tc2 |
SH3 domain and tetratricopeptide repeats 2 |
115 |
0.97 |
chr7_16312698_16312957 | 4.04 |
Bbc3 |
BCL2 binding component 3 |
690 |
0.56 |
chr1_74962493_74962791 | 4.03 |
Gm37744 |
predicted gene, 37744 |
8390 |
0.12 |
chr3_65658208_65659857 | 4.02 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr10_127508848_127510720 | 3.98 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr1_134559997_134561478 | 3.97 |
Kdm5b |
lysine (K)-specific demethylase 5B |
530 |
0.69 |
chr7_19672153_19672312 | 3.96 |
Apoc2 |
apolipoprotein C-II |
1688 |
0.16 |
chr4_148040533_148041286 | 3.96 |
Mthfr |
methylenetetrahydrofolate reductase |
99 |
0.92 |
chr14_30888293_30888745 | 3.95 |
Itih4 |
inter alpha-trypsin inhibitor, heavy chain 4 |
1998 |
0.21 |
chr11_30648868_30649937 | 3.92 |
Acyp2 |
acylphosphatase 2, muscle type |
185 |
0.95 |
chr9_53409613_53409764 | 3.90 |
4930550C14Rik |
RIKEN cDNA 4930550C14 gene |
4390 |
0.18 |
chr4_45341633_45342861 | 3.88 |
Dcaf10 |
DDB1 and CUL4 associated factor 10 |
65 |
0.87 |
chr11_95824572_95825174 | 3.88 |
Phospho1 |
phosphatase, orphan 1 |
373 |
0.77 |
chr5_134313726_134314672 | 3.87 |
Gtf2i |
general transcription factor II I |
179 |
0.92 |
chr11_120850773_120850926 | 3.86 |
Gm11773 |
predicted gene 11773 |
19820 |
0.09 |
chr1_184629485_184629636 | 3.86 |
Gm37800 |
predicted gene, 37800 |
87 |
0.97 |
chr5_142920749_142921092 | 3.85 |
Actb |
actin, beta |
14166 |
0.14 |
chr15_80743116_80743287 | 3.84 |
Gm49512 |
predicted gene, 49512 |
30930 |
0.13 |
chr11_82870435_82870638 | 3.84 |
Rffl |
ring finger and FYVE like domain containing protein |
208 |
0.88 |
chr6_49215408_49216029 | 3.83 |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
761 |
0.6 |
chr14_79390171_79390957 | 3.82 |
Naa16 |
N(alpha)-acetyltransferase 16, NatA auxiliary subunit |
126 |
0.95 |
chr15_102191786_102191999 | 3.81 |
Csad |
cysteine sulfinic acid decarboxylase |
167 |
0.91 |
chr11_115838815_115839188 | 3.81 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
4678 |
0.11 |
chr15_101242717_101242959 | 3.78 |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
11431 |
0.09 |
chr11_96917538_96917802 | 3.78 |
Cdk5rap3 |
CDK5 regulatory subunit associated protein 3 |
1174 |
0.24 |
chr11_117204633_117204995 | 3.76 |
Septin9 |
septin 9 |
5153 |
0.19 |
chr6_86832842_86833107 | 3.76 |
2610306M01Rik |
RIKEN cDNA 2610306M01 gene |
16466 |
0.12 |
chr2_152811266_152811807 | 3.75 |
Bcl2l1 |
BCL2-like 1 |
16999 |
0.11 |
chr6_34877500_34878315 | 3.75 |
Cyren |
cell cycle regulator of NHEJ |
102 |
0.95 |
chr9_7780394_7780557 | 3.75 |
Mir5618 |
microRNA 5618 |
3915 |
0.17 |
chr8_87961261_87962490 | 3.74 |
Zfp423 |
zinc finger protein 423 |
2280 |
0.39 |
chr13_97299991_97300171 | 3.73 |
C430039J16Rik |
RIKEN cDNA C430039J16 gene |
16898 |
0.18 |
chr17_12378400_12378705 | 3.72 |
Plg |
plasminogen |
56 |
0.97 |
chr14_30625072_30625540 | 3.72 |
Prkcd |
protein kinase C, delta |
866 |
0.53 |
chr13_63567343_63568686 | 3.71 |
A930032L01Rik |
RIKEN cDNA A930032L01 gene |
40 |
0.96 |
chr5_122145801_122145983 | 3.71 |
Ccdc63 |
coiled-coil domain containing 63 |
5069 |
0.14 |
chr14_25606696_25608421 | 3.70 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
201 |
0.95 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 18.4 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
3.2 | 9.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
2.3 | 6.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
2.1 | 12.7 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
1.9 | 5.8 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.7 | 8.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
1.7 | 5.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.6 | 6.5 | GO:0007296 | vitellogenesis(GO:0007296) |
1.6 | 1.6 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.5 | 5.9 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.5 | 5.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.5 | 5.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.4 | 4.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.4 | 4.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.4 | 5.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.4 | 5.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.4 | 2.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.3 | 5.3 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.3 | 2.6 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.3 | 3.9 | GO:0008050 | female courtship behavior(GO:0008050) |
1.3 | 7.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.3 | 3.8 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
1.3 | 3.8 | GO:0000087 | mitotic M phase(GO:0000087) |
1.2 | 3.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.2 | 3.7 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.2 | 3.7 | GO:1903416 | response to glycoside(GO:1903416) |
1.2 | 4.9 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.2 | 3.6 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
1.2 | 6.0 | GO:0070836 | caveola assembly(GO:0070836) |
1.2 | 4.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.2 | 3.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.2 | 1.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.2 | 6.9 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.1 | 9.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.1 | 3.4 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.1 | 2.3 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
1.1 | 15.9 | GO:0043486 | histone exchange(GO:0043486) |
1.1 | 1.1 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
1.1 | 3.4 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.1 | 6.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
1.1 | 3.3 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.1 | 3.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.1 | 6.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.1 | 4.3 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
1.1 | 4.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.1 | 3.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.0 | 3.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.0 | 5.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.0 | 7.3 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
1.0 | 3.1 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
1.0 | 4.1 | GO:0032264 | IMP salvage(GO:0032264) |
1.0 | 2.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.0 | 2.0 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
1.0 | 1.0 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.0 | 6.0 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
1.0 | 3.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.0 | 2.0 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.0 | 1.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
1.0 | 2.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.0 | 3.9 | GO:0043622 | cortical microtubule organization(GO:0043622) |
1.0 | 2.9 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.0 | 2.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.0 | 5.8 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.0 | 2.9 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.9 | 2.8 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.9 | 2.8 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.9 | 2.8 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.9 | 1.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.9 | 1.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.9 | 4.6 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.9 | 9.3 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.9 | 3.7 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.9 | 3.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.9 | 2.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.9 | 3.6 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.9 | 6.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.9 | 3.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.9 | 4.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.9 | 0.9 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.9 | 2.7 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.9 | 2.6 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.9 | 5.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.9 | 7.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.9 | 1.7 | GO:0036166 | phenotypic switching(GO:0036166) |
0.9 | 3.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.9 | 3.4 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.8 | 5.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.8 | 3.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.8 | 3.3 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.8 | 3.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.8 | 2.5 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.8 | 2.5 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.8 | 4.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.8 | 5.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.8 | 2.4 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.8 | 0.8 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.8 | 2.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.8 | 0.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.8 | 3.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.8 | 4.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.8 | 0.8 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.8 | 7.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.8 | 3.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.8 | 0.8 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.8 | 3.9 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.8 | 3.9 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.8 | 7.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
0.8 | 3.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.8 | 2.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.7 | 2.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.7 | 8.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.7 | 3.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.7 | 2.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.7 | 3.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.7 | 2.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.7 | 0.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.7 | 7.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.7 | 2.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.7 | 0.7 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.7 | 2.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.7 | 1.4 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.7 | 0.7 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.7 | 2.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.7 | 0.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.7 | 1.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.7 | 2.8 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.7 | 2.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.7 | 2.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.7 | 2.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.7 | 2.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.7 | 2.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.7 | 2.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.7 | 3.4 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.7 | 2.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.7 | 2.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.7 | 1.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.7 | 2.0 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.7 | 2.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.7 | 2.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.7 | 1.3 | GO:1905065 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.7 | 2.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.7 | 1.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.6 | 0.6 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.6 | 1.9 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.6 | 1.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.6 | 1.9 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.6 | 1.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.6 | 9.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.6 | 3.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.6 | 2.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.6 | 2.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.6 | 1.9 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.6 | 0.6 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.6 | 1.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.6 | 1.9 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.6 | 2.5 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.6 | 1.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.6 | 3.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.6 | 1.9 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.6 | 1.3 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.6 | 1.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.6 | 1.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.6 | 1.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 2.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.6 | 2.4 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.6 | 3.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.6 | 0.6 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.6 | 1.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.6 | 4.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.6 | 3.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.6 | 0.6 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.6 | 2.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.6 | 1.8 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.6 | 1.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.6 | 1.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.6 | 1.8 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.6 | 2.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.6 | 1.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.6 | 0.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.6 | 1.7 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.6 | 8.7 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.6 | 2.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.6 | 1.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.6 | 8.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.6 | 2.3 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.6 | 2.3 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.6 | 1.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.6 | 3.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.6 | 2.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.6 | 4.6 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.6 | 1.7 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.6 | 1.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.6 | 1.7 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.6 | 2.3 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.6 | 1.7 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.6 | 1.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.6 | 1.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.6 | 2.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.6 | 1.1 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.6 | 1.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.6 | 1.7 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.6 | 2.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.6 | 1.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.6 | 2.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.6 | 4.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 2.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.5 | 2.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.5 | 0.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.5 | 2.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 1.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.5 | 3.2 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.5 | 2.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.5 | 1.6 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.5 | 1.6 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.5 | 2.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.5 | 1.6 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.5 | 1.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 6.4 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.5 | 1.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.5 | 1.1 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.5 | 1.6 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.5 | 0.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.5 | 1.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.5 | 1.0 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.5 | 2.1 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.5 | 1.5 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.5 | 0.5 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.5 | 4.6 | GO:0030575 | nuclear body organization(GO:0030575) |
0.5 | 2.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 2.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.5 | 1.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 6.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.5 | 2.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.5 | 5.0 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.5 | 4.0 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.5 | 4.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.5 | 3.0 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 1.0 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.5 | 1.5 | GO:0030952 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.5 | 2.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.5 | 4.0 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.5 | 0.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.5 | 1.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.5 | 2.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 1.0 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.5 | 1.5 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.5 | 4.0 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.5 | 0.5 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 2.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.5 | 0.5 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.5 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.5 | 1.0 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.5 | 0.5 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.5 | 2.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.5 | 1.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.5 | 1.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.5 | 1.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.5 | 1.4 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.5 | 1.4 | GO:0061140 | lung secretory cell differentiation(GO:0061140) |
0.5 | 7.2 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.5 | 1.9 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.5 | 1.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.5 | 2.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.5 | 0.9 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.5 | 1.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.5 | 1.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 6.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.5 | 1.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.5 | 2.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.5 | 1.9 | GO:0090148 | membrane fission(GO:0090148) |
0.5 | 7.0 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.5 | 1.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.5 | 1.9 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 1.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.5 | 1.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.5 | 2.3 | GO:0036233 | glycine import(GO:0036233) |
0.5 | 1.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.5 | 0.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.5 | 1.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 1.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.5 | 0.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.5 | 2.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.5 | 0.9 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.5 | 2.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 0.4 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.4 | 1.3 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.4 | 1.8 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.4 | 1.3 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 4.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.4 | 2.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.4 | 0.4 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.4 | 0.4 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.4 | 0.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 1.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 0.4 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.4 | 2.2 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.4 | 1.3 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.4 | 0.9 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 10.6 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.4 | 1.3 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.4 | 1.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 0.9 | GO:0003166 | bundle of His development(GO:0003166) |
0.4 | 7.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.4 | 3.9 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.4 | 1.7 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.4 | 4.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.4 | 2.6 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.4 | 1.3 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.4 | 0.4 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.4 | 1.3 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
0.4 | 0.9 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.4 | 1.3 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.4 | 0.4 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.4 | 1.7 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.4 | 0.4 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.4 | 1.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 1.3 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.4 | 1.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 0.8 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.4 | 1.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 1.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 2.9 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.4 | 0.4 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.4 | 1.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 1.6 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.4 | 1.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.4 | 1.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.4 | 2.0 | GO:0018101 | protein citrullination(GO:0018101) |
0.4 | 0.8 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.4 | 2.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.4 | 2.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.4 | 2.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.4 | 2.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.4 | 2.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.4 | 0.8 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.4 | 2.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.4 | 1.2 | GO:0044038 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.4 | 2.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.4 | 2.0 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.4 | 0.8 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.4 | 1.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.4 | 1.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 0.4 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.4 | 0.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.4 | 3.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.4 | 1.6 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 2.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.4 | 3.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.4 | 0.8 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 0.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.4 | 1.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.4 | 9.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.4 | 1.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 0.8 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.4 | 0.8 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.4 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 1.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 0.8 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 0.8 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.4 | 2.6 | GO:0042730 | fibrinolysis(GO:0042730) |
0.4 | 3.4 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.4 | 1.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.4 | 2.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 1.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.4 | 0.4 | GO:0050904 | diapedesis(GO:0050904) |
0.4 | 0.4 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 6.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 0.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.4 | 3.6 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 1.1 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.4 | 1.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.4 | 1.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.4 | 2.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.4 | 1.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.4 | 1.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.4 | 1.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.4 | 1.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 1.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.4 | 0.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.4 | 0.4 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.4 | 1.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.4 | 3.9 | GO:0036035 | osteoclast development(GO:0036035) |
0.4 | 1.4 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.4 | 1.4 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.3 | 1.0 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 0.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.3 | 2.4 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 2.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 1.0 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.3 | 1.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 1.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 2.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 1.4 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.3 | 2.7 | GO:0001553 | luteinization(GO:0001553) |
0.3 | 1.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 0.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.3 | 4.1 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 0.7 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 0.7 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 1.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.3 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.3 | 1.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 1.0 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.3 | 1.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 2.3 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.3 | 1.3 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.3 | 1.0 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.3 | 1.6 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 6.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.3 | 1.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 1.6 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.3 | 2.6 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.3 | 5.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 2.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.3 | 1.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 1.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 1.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 1.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 0.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 2.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.3 | 0.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 1.0 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.3 | 0.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.3 | 0.6 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.3 | 2.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 0.3 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.3 | 1.0 | GO:0061042 | vascular wound healing(GO:0061042) |
0.3 | 0.6 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.3 | 0.3 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.3 | 0.9 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.3 | 4.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 5.0 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.3 | 0.6 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.3 | 3.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 0.9 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.3 | 0.9 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 0.9 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 0.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 3.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 3.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.3 | 2.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 0.6 | GO:0006573 | valine metabolic process(GO:0006573) |
0.3 | 0.6 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.3 | 0.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 0.9 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 0.6 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.3 | 2.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 1.2 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.3 | 3.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 5.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.3 | 1.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.3 | 0.3 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.3 | 1.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.3 | 0.9 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.3 | 0.9 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 0.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.3 | 0.9 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 3.0 | GO:0046464 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.3 | 3.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 1.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.3 | 3.2 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 | 0.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 2.6 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.3 | 0.3 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 1.2 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.3 | 0.9 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 0.9 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 1.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.3 | 0.6 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.3 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 0.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.3 | 0.6 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.3 | 0.6 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.3 | 2.2 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.3 | 1.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.3 | 0.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.3 | 2.8 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.3 | 0.8 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.3 | 0.6 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 1.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 1.1 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.3 | 0.8 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 0.3 | GO:0045923 | positive regulation of fatty acid metabolic process(GO:0045923) |
0.3 | 2.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 8.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 1.1 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.3 | 0.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.3 | 5.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.3 | 0.3 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.3 | 1.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 0.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 1.1 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.3 | 4.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 0.3 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.3 | 1.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.3 | 1.3 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 1.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.3 | 0.3 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 1.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 3.6 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.3 | 1.0 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.3 | 1.3 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.3 | 0.8 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 0.8 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.3 | 0.3 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.3 | 1.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 1.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 0.3 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.3 | 0.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 1.0 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 5.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.3 | 1.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 1.3 | GO:0045006 | DNA deamination(GO:0045006) |
0.3 | 3.6 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.3 | 0.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 1.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 1.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.3 | 2.8 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.3 | 0.5 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 2.3 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.3 | 0.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 1.0 | GO:0009414 | response to water deprivation(GO:0009414) |
0.2 | 0.5 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 1.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.2 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 3.0 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 3.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 2.5 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 1.9 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 1.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 1.0 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 1.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.2 | 1.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 1.2 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.2 | 0.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 4.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 0.7 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 0.5 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.2 | 0.5 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 2.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 2.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 2.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 1.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 1.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.9 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 1.4 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.2 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.5 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.2 | 0.7 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.2 | 1.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 1.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 0.9 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 1.1 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 1.4 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.2 | 0.7 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 0.5 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.2 | 1.6 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.2 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 1.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.9 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 2.0 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.2 | 0.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 1.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 2.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.9 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.2 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.2 | 2.0 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.2 | 1.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.2 | 0.9 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 3.7 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.2 | 0.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 2.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 3.7 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 1.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 0.2 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.2 | 0.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 1.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 1.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 3.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.2 | 1.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 0.6 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.2 | 0.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.6 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 3.2 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.2 | 2.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 2.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.4 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.2 | 0.2 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.2 | 1.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 0.4 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.2 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 2.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 2.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 1.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 0.4 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.2 | 2.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 1.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 1.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 0.6 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.2 | 6.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 1.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 1.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 1.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 7.8 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.2 | 0.4 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.2 | 1.2 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 1.2 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 0.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.6 | GO:0097286 | iron ion import(GO:0097286) |
0.2 | 3.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.4 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 4.9 | GO:0001885 | endothelial cell development(GO:0001885) |
0.2 | 0.6 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.2 | 0.2 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 10.1 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.2 | 0.6 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.2 | 0.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 1.2 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 13.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 1.0 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.6 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 1.3 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.2 | 0.6 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.2 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.2 | GO:0072537 | fibroblast activation(GO:0072537) |
0.2 | 2.8 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.2 | 0.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.4 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 1.7 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 0.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.4 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 1.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.2 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.2 | 2.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 0.2 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.9 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 0.4 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.2 | 1.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.2 | 0.2 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 0.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 0.4 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.2 | 2.2 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.2 | 1.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 1.6 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 3.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 2.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 0.7 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.2 | 0.5 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.2 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 2.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 0.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 1.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 1.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 2.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 1.6 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 0.3 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.2 | 0.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.5 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 1.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 1.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.3 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.2 | 0.3 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 0.5 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.2 | 0.5 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 0.3 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 0.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 2.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.2 | 3.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.5 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 1.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 0.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.8 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.2 | 6.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 0.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.7 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.2 | 1.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 1.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.5 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.2 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.2 | GO:0072141 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) |
0.2 | 2.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 2.3 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.6 | GO:0015840 | urea transport(GO:0015840) |
0.2 | 0.8 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 1.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 0.8 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.2 | 0.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 1.0 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 0.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.8 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
0.2 | 2.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.2 | 0.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.2 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.2 | 1.6 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 0.8 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 0.3 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 0.3 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.2 | 0.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.2 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.2 | 0.5 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 2.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 1.4 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.2 | 0.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 0.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 0.5 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 1.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.7 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.3 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.6 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.4 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.9 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 1.8 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 2.9 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 0.3 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.9 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.3 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.9 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.4 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.3 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.1 | 2.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.8 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 1.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 1.1 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 1.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 1.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.1 | GO:0007619 | courtship behavior(GO:0007619) |
0.1 | 0.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.9 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.4 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 0.9 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.4 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.1 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.8 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.7 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.1 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.1 | 0.6 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 0.1 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.1 | 1.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 3.6 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.1 | 0.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.4 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 2.0 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 1.4 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 1.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.1 | GO:0046641 | regulation of alpha-beta T cell proliferation(GO:0046640) positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 1.3 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.5 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.4 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.5 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.7 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.5 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 1.1 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.1 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
0.1 | 1.4 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.6 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 1.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.8 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.4 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 1.2 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 2.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.7 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.5 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.5 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.2 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.7 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.6 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 1.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.9 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.7 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 0.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.4 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.1 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.1 | 0.4 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.3 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 1.2 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.1 | 0.3 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 1.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 2.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 0.4 | GO:0044821 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 1.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.1 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.1 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 2.9 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 2.9 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.3 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.1 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.8 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.3 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.5 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.8 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.2 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 1.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.3 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 1.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.6 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.1 | 0.1 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.1 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.6 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 1.8 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.2 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.1 | 0.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.4 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.1 | 0.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 1.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.1 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.1 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 1.7 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.3 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 1.9 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 2.0 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.1 | 0.3 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.1 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.1 | 1.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 1.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.5 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.1 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 2.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.5 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 1.0 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 1.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.6 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 1.8 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.1 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.1 | 0.2 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 0.3 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.3 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.2 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.6 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.7 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.4 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.2 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.1 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.4 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 0.2 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.7 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 1.0 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 2.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.2 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.1 | GO:2000407 | regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.1 | 1.6 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.7 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.7 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.6 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.1 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) regulation of neural retina development(GO:0061074) |
0.1 | 0.2 | GO:0042116 | macrophage activation(GO:0042116) |
0.1 | 0.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.1 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.7 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.5 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.3 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.4 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.1 | 0.5 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.1 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.1 | 0.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.1 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.1 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.3 | GO:0014857 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.3 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.1 | 0.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.4 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.4 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.5 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.4 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.1 | 0.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.4 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.1 | 0.1 | GO:0071599 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 1.1 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.6 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 1.3 | GO:0098840 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.4 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.3 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 1.1 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.2 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.1 | 1.7 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.1 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.1 | 0.4 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.1 | GO:0010042 | response to manganese ion(GO:0010042) response to cobalt ion(GO:0032025) |
0.1 | 0.3 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.1 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 1.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.8 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.5 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 0.1 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.1 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:2000142 | regulation of DNA-templated transcription, initiation(GO:2000142) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.1 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.1 | 0.6 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.1 | 0.4 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
0.1 | 0.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.1 | 0.2 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.1 | GO:0060547 | negative regulation of necroptotic process(GO:0060546) negative regulation of necrotic cell death(GO:0060547) |
0.1 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.6 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.1 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 1.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.2 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.3 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.1 | 0.4 | GO:0006026 | aminoglycan catabolic process(GO:0006026) chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.3 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.1 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 1.4 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 2.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.2 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.1 | 0.2 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 2.0 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.1 | 0.1 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.1 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 0.1 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 0.2 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.1 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.1 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.1 | 2.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.0 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.0 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.0 | 0.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.2 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.1 | GO:1903580 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.0 | 0.5 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.0 | 0.1 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.0 | 0.1 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.0 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.1 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.0 | 0.0 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.5 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.0 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.0 | 0.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.0 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.0 | 0.0 | GO:0010939 | regulation of necrotic cell death(GO:0010939) |
0.0 | 0.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.3 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.2 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.0 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 2.1 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.4 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.0 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.0 | 0.1 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 4.4 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.0 | GO:0061384 | heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.0 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.0 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.0 | 0.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.0 | 0.0 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.0 | 0.0 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.0 | 0.7 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 1.6 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.2 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
0.0 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.0 | 0.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.1 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.0 | 0.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.0 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) positive regulation of steroid metabolic process(GO:0045940) |
0.0 | 0.1 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.0 | 0.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:2000851 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of glucocorticoid secretion(GO:2000851) |
0.0 | 0.1 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.0 | 0.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.5 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.0 | 0.4 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.0 | 0.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.0 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0050932 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.0 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.0 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.1 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.4 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.2 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.6 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.0 | 0.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.1 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.3 | GO:0051591 | response to cAMP(GO:0051591) |
0.0 | 0.0 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.0 | 0.2 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.2 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.0 | 0.1 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.0 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.3 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.0 | 0.3 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.0 | 0.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.0 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.0 | 0.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.0 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 4.8 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 1.1 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.0 | 0.0 | GO:1903203 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
0.0 | 0.0 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.1 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.0 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.0 | 0.0 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.0 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.4 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.0 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.0 | 0.0 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.0 | 0.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.0 | 0.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.0 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.0 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.1 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.0 | GO:0035930 | corticosteroid hormone secretion(GO:0035930) regulation of corticosteroid hormone secretion(GO:2000846) |
0.0 | 0.8 | GO:0051297 | centrosome organization(GO:0051297) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.0 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.0 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.0 | 0.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.0 | 0.1 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.0 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.0 | 0.0 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.0 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.0 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0034311 | diol metabolic process(GO:0034311) |
0.0 | 0.1 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.0 | 0.0 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.0 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.0 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.0 | 0.0 | GO:0044062 | regulation of excretion(GO:0044062) |
0.0 | 0.0 | GO:0000723 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.0 | 0.0 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.7 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.0 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 14.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.6 | 6.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.6 | 7.9 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.5 | 7.7 | GO:0008091 | spectrin(GO:0008091) |
1.2 | 1.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.2 | 4.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.1 | 3.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.1 | 3.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.1 | 4.4 | GO:0072487 | MSL complex(GO:0072487) |
1.0 | 4.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.0 | 3.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.0 | 7.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.9 | 2.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.9 | 5.6 | GO:0031415 | NatA complex(GO:0031415) |
0.9 | 2.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.9 | 2.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.9 | 3.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.9 | 2.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 2.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.8 | 2.5 | GO:0043293 | apoptosome(GO:0043293) |
0.8 | 4.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.8 | 3.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.8 | 3.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.8 | 2.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.8 | 2.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.8 | 3.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.7 | 5.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.7 | 5.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.7 | 2.8 | GO:1990130 | Iml1 complex(GO:1990130) |
0.7 | 3.5 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.7 | 2.7 | GO:0097452 | GAIT complex(GO:0097452) |
0.6 | 2.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.6 | 5.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 18.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.6 | 3.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.6 | 2.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.6 | 4.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.6 | 5.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.6 | 1.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 3.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.6 | 2.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 6.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.6 | 2.9 | GO:0005638 | lamin filament(GO:0005638) |
0.6 | 2.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 1.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.6 | 1.7 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 2.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.6 | 1.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 7.1 | GO:0036038 | MKS complex(GO:0036038) |
0.5 | 5.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.5 | 4.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 3.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.5 | 2.6 | GO:0030870 | Mre11 complex(GO:0030870) |
0.5 | 2.0 | GO:0035339 | SPOTS complex(GO:0035339) |
0.5 | 3.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.5 | 4.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 3.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.5 | 3.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 4.3 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.5 | 32.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.5 | 6.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.5 | 7.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.5 | 1.9 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.5 | 0.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.5 | 0.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.5 | 5.9 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.4 | 4.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.4 | 4.0 | GO:0032797 | SMN complex(GO:0032797) |
0.4 | 2.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.4 | 2.2 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.4 | 4.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.4 | 3.4 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 3.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 3.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 3.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 1.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 1.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 2.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 4.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 6.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 2.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.4 | 2.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 0.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.4 | 1.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.4 | 3.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 1.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 1.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.4 | 1.1 | GO:0000811 | GINS complex(GO:0000811) |
0.4 | 10.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 5.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 0.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 1.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 2.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.3 | 2.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 4.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.3 | 2.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 2.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 1.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 1.0 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 2.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 1.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 0.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 1.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 5.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 4.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 0.3 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.3 | 1.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 4.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 7.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 0.9 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 3.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 1.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 2.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 1.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.3 | 3.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 1.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 2.4 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.3 | 1.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 6.2 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 1.2 | GO:0042825 | TAP complex(GO:0042825) |
0.3 | 1.2 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 13.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 2.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 1.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 6.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 4.0 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 0.9 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 0.9 | GO:1990423 | RZZ complex(GO:1990423) |
0.3 | 0.8 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 3.1 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 7.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 11.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 1.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 4.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 0.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 2.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 1.4 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 1.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 2.1 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 0.5 | GO:0043205 | fibril(GO:0043205) |
0.3 | 1.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 2.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 2.0 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.3 | 1.0 | GO:0000938 | GARP complex(GO:0000938) |
0.3 | 2.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.5 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 7.9 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 2.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 1.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 1.9 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 0.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 1.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.7 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 0.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 1.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 0.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 1.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 0.9 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 0.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.9 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 3.6 | GO:0043034 | costamere(GO:0043034) |
0.2 | 4.5 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.2 | 3.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 1.5 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 1.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 1.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 10.9 | GO:0016605 | PML body(GO:0016605) |
0.2 | 11.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.6 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 0.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 1.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 1.1 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.2 | 0.9 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 0.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 9.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 2.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.2 | 17.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 1.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 0.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 0.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 2.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 10.1 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.6 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 3.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 11.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 0.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 1.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.2 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.4 | GO:0001940 | female pronucleus(GO:0001939) male pronucleus(GO:0001940) |
0.2 | 1.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 1.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 0.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 1.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 4.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 1.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 2.4 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 0.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 1.7 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.2 | 0.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 3.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 2.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 0.5 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 0.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 1.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.4 | GO:0034399 | nuclear periphery(GO:0034399) |
0.2 | 1.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 1.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 1.9 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 5.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.5 | GO:0005818 | aster(GO:0005818) |
0.2 | 1.0 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 1.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 3.2 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.2 | 0.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 0.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 20.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 0.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 1.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 1.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 15.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 1.5 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 1.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.0 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 1.8 | GO:0031430 | M band(GO:0031430) |
0.1 | 1.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.9 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 13.5 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 2.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 1.7 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.1 | 8.6 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 1.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 2.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 1.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 144.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 1.8 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.9 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 2.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 1.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 1.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 35.0 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.6 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 4.3 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 6.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 35.8 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.3 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 0.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.5 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.4 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.6 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.3 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.5 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.9 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 1.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.9 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 3.0 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.8 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 1.2 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 2.3 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 1.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 1.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 59.8 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 3.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 4.2 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 2.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 1.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 6.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 2.5 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 2.7 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 10.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 1.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 27.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.0 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 5.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.9 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 1.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.1 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.0 | GO:1990812 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.0 | 0.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 0.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.0 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.2 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.6 | GO:0070013 | intracellular organelle lumen(GO:0070013) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 1.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.0 | GO:0045180 | basal cortex(GO:0045180) cell cortex region(GO:0099738) |
0.0 | 1.0 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 1.5 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.0 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 16.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.0 | 6.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.9 | 5.7 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.8 | 7.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.7 | 8.3 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
1.4 | 4.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.4 | 4.1 | GO:0008142 | oxysterol binding(GO:0008142) |
1.3 | 4.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.3 | 3.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.2 | 7.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.2 | 4.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.2 | 1.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.2 | 6.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.1 | 4.6 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.1 | 12.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.1 | 3.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.1 | 3.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
1.1 | 6.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.1 | 4.3 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.1 | 4.2 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.0 | 8.4 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.0 | 4.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.0 | 3.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.0 | 4.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.9 | 5.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.9 | 2.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.9 | 2.8 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.9 | 2.8 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.9 | 0.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.9 | 6.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.9 | 2.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.9 | 3.5 | GO:0009374 | biotin binding(GO:0009374) |
0.9 | 3.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.9 | 3.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.9 | 7.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.8 | 1.7 | GO:1990188 | euchromatin binding(GO:1990188) |
0.8 | 2.5 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.8 | 5.8 | GO:0034046 | poly(G) binding(GO:0034046) |
0.8 | 2.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.8 | 2.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.8 | 2.4 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.8 | 7.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.8 | 2.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.8 | 0.8 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.8 | 3.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.8 | 4.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.8 | 4.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.8 | 4.6 | GO:0000182 | rDNA binding(GO:0000182) |
0.8 | 3.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.8 | 3.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.8 | 3.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.7 | 2.9 | GO:0031014 | troponin T binding(GO:0031014) |
0.7 | 9.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.7 | 5.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.7 | 6.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.7 | 3.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.7 | 2.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.7 | 2.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.7 | 5.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.7 | 2.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.7 | 4.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.7 | 3.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.7 | 2.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.7 | 0.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.7 | 11.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.7 | 2.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.7 | 3.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.7 | 2.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.6 | 3.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 2.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 0.6 | GO:0070538 | oleic acid binding(GO:0070538) |
0.6 | 4.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 1.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.6 | 3.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 2.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 6.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.6 | 3.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.6 | 6.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.6 | 2.4 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.6 | 4.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 3.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.6 | 1.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.6 | 7.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.6 | 2.3 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 2.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 1.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 2.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.6 | 2.8 | GO:0071253 | connexin binding(GO:0071253) |
0.6 | 2.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.6 | 1.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.6 | 13.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.5 | 7.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.5 | 4.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 2.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.5 | 1.6 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 5.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.5 | 4.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.5 | 4.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.5 | 2.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 7.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.5 | 3.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.5 | 2.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.5 | 0.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.5 | 2.0 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.5 | 2.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.5 | 1.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.5 | 1.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.5 | 1.9 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.5 | 3.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.5 | 3.8 | GO:0008430 | selenium binding(GO:0008430) |
0.5 | 1.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.5 | 3.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 2.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 3.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 5.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 1.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.5 | 2.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.5 | 1.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.5 | 1.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.5 | 1.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.5 | 1.4 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.5 | 3.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.5 | 1.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.5 | 3.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.4 | 1.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 1.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 23.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.4 | 1.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 4.8 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.4 | 2.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.4 | 1.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 2.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.4 | 1.3 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.4 | 7.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.4 | 2.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 1.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.4 | 3.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 1.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.4 | 2.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 1.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.4 | 1.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 1.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.4 | 2.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 2.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.4 | 1.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 3.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.4 | 0.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.4 | 1.6 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.4 | 3.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 1.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 2.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 2.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 5.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 4.2 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.4 | 3.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 16.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.4 | 1.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 1.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 2.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.4 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.4 | 1.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 1.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 1.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.4 | 6.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.4 | 2.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 1.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.4 | 1.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 2.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 4.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.3 | 0.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.3 | 3.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 1.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.3 | 4.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 1.7 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 1.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.3 | 3.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 1.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 1.0 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.3 | 1.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 0.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 2.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 1.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.3 | 2.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 1.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 5.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 2.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.3 | 1.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 1.3 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.3 | 1.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 4.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 1.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 4.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 0.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 1.9 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 3.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 0.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.3 | 0.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 0.9 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 1.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 1.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 2.1 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.3 | 1.2 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 0.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 1.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 6.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 0.9 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 2.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 0.6 | GO:0030172 | troponin C binding(GO:0030172) |
0.3 | 2.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 0.6 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.3 | 1.7 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 1.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 0.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.3 | 2.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 4.8 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.3 | 1.7 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 3.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 1.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 8.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 8.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 0.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 0.8 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 6.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 0.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.3 | 3.2 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.3 | 1.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 2.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 2.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 3.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.3 | 4.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 1.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 0.5 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 1.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 0.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 1.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 0.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 0.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 2.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 4.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 1.8 | GO:0034534 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 0.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 1.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 1.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 2.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 9.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 1.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 3.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 23.7 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 2.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 1.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 3.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 5.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 1.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 3.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 2.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 2.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 2.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 29.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.2 | 1.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 0.9 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 7.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 2.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.9 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.2 | 1.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 2.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.7 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 0.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 43.1 | GO:0043774 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.2 | 1.4 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 0.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 1.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 1.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 0.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 2.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.7 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 1.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.7 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 6.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.6 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 0.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 1.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 0.6 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 2.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 11.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 0.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 2.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 10.5 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.2 | 1.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 1.2 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 1.0 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 2.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 3.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 2.0 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 0.4 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.2 | 0.6 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 1.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 0.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 0.6 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.2 | 0.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 3.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 5.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 0.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 0.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 3.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 3.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 1.7 | GO:0034901 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 1.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 4.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
0.2 | 2.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 5.8 | GO:0080030 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.2 | 0.5 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 0.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 1.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 1.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 3.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 0.5 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 1.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 0.5 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 2.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 0.5 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 4.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 1.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 1.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.7 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.2 | 2.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.2 | 0.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 1.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 7.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 4.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 1.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 0.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 1.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 10.2 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.2 | 0.2 | GO:0016401 | acyl-CoA oxidase activity(GO:0003997) palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 2.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.6 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.9 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 3.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 2.0 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 1.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 16.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.3 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 1.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 3.6 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 0.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 1.6 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 1.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 1.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.4 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 6.2 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 11.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 1.0 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 1.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 8.2 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 2.8 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 3.4 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 1.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.4 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 1.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.5 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.5 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 1.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 6.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 1.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 23.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 1.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 3.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 2.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 5.8 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 1.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 3.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 1.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 2.4 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 1.3 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.3 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.6 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 3.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 2.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.9 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.3 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 1.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 1.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.9 | GO:0043762 | acyl-CoA ligase activity(GO:0003996) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.4 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 1.1 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 1.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 1.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 2.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.3 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 1.3 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.5 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 1.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 1.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 2.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 3.8 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 0.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 2.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.5 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 4.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.6 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 1.6 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 1.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 2.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 2.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 1.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 42.2 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.3 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.2 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 1.5 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 4.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 1.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.2 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 2.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 5.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 1.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.8 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 9.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 2.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 1.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 1.5 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.6 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.1 | 0.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.6 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.4 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 1.2 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 2.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 1.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.1 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.0 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.0 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.0 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 1.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 1.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 1.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.1 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 3.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.2 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.2 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.0 | 0.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.2 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.0 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.0 | 0.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.2 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.0 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.0 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.1 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.0 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.0 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.6 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 12.5 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.2 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.0 | GO:0070990 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.0 | 0.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 21.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.9 | 7.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.8 | 8.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.7 | 5.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.7 | 17.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.7 | 6.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.6 | 6.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 17.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.6 | 9.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 19.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.6 | 38.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 3.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.5 | 13.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.4 | 16.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 18.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 10.6 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.4 | 5.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 6.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 0.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 10.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 3.3 | PID MYC PATHWAY | C-MYC pathway |
0.4 | 2.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 3.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 4.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 3.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 4.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 3.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 4.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 10.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 4.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 11.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 3.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 0.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 12.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 7.8 | PID ATM PATHWAY | ATM pathway |
0.3 | 1.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 1.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 12.5 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 3.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 6.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 1.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 4.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 7.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 5.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 0.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 1.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 5.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 10.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 3.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 4.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 1.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 1.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 6.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 2.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 1.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 5.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 1.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 2.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 4.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 4.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 3.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 2.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 8.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 5.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 5.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 0.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 1.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 5.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 2.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 1.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 1.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 0.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 1.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 1.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 1.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 3.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 3.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 2.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 3.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 4.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 2.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 23.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
1.1 | 5.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.1 | 1.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.8 | 8.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.8 | 7.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 12.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.7 | 0.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.7 | 8.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.7 | 5.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.7 | 11.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.7 | 10.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.7 | 6.6 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.6 | 6.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.6 | 8.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.6 | 7.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.6 | 0.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.6 | 13.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.6 | 1.7 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.6 | 7.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.5 | 7.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.5 | 6.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.5 | 8.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 10.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.5 | 5.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.5 | 6.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.5 | 5.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.5 | 4.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 2.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.5 | 4.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 1.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.5 | 4.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 0.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.4 | 4.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 3.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.4 | 0.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 2.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 10.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 2.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.4 | 1.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.4 | 2.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.4 | 19.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 7.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 6.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 7.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.4 | 6.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 3.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.4 | 1.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.4 | 4.9 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.4 | 0.7 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 6.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 2.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 5.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 3.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 4.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 6.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 1.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 7.0 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.3 | 9.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 4.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 1.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 3.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 5.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 5.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 5.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 7.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 0.3 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.3 | 4.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 5.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 6.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 21.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 4.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.3 | 4.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.3 | 3.8 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.3 | 7.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 2.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 0.9 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 5.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 0.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 2.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 3.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 8.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 3.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 10.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 2.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 4.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 1.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 3.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 1.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 5.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 2.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 4.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 2.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 2.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 5.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 1.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 2.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 3.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 0.4 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.2 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 3.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 1.2 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.2 | 13.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 5.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 1.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 0.6 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.2 | 1.3 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.2 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 1.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 3.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 0.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 26.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 8.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 0.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 1.5 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 4.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 5.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 2.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 1.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 1.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 4.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 1.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 1.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 2.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 1.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 2.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 3.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.7 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 0.5 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 2.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 2.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 1.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 4.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.4 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.1 | 1.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.0 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 2.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 1.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.7 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.2 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 1.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 4.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 0.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 2.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 9.1 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.1 | 1.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 2.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 3.0 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 0.5 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 2.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 3.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 7.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.6 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 3.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 3.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.3 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 2.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 1.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 2.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 1.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 1.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.5 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 2.4 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 3.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.3 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.0 | 0.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.0 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.0 | REACTOME S PHASE | Genes involved in S Phase |
0.0 | 0.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |